The Delta variant of COVID-19 continues to spread through the U.S., with Missouri and Kansas seeing high transmission as vaccination efforts remain sluggish in some parts of the country.
The risk of catching COVID-19 sent many in search of tests at the first signs of a common cold over the past year, and now as the nation gradually reopens there is an increased chance you will come into contact with someone carrying a summer cold.
The Centers for Disease Control and Prevention (CDC) national surveillance system has noted an uptick in the number of respiratory syncytial virus (RSV) cases detected in the U.S. over the last several weeks, noting that the illness can be associated with severe disease in young children and older adults.
Doctors are warning over a dangerous TikTok challenge involving fake tongue piercings with magnetic balls, said to pose a deadly risk if the magnets are swallowed.
Canada's National Advisory Committee on Immunization said Thursday people who got the AstraZeneca vaccine as their first dose should get Pfizer-BioNTech or Moderna for their second shot.
Friday’s scheduled CDC panel discussion on reports of heart inflammation among a small fraction of COVID-19 vaccine recipients has been postponed in observance of the Juneteenth National Independence Day holiday, the agency said.
The United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics.
The U.K.'s latest surge in coronavirus infections gathered pace Thursday with new confirmed cases rising above 10,000 for the first time in nearly four months as a result of the spread of the more contagious delta variant.
A top official with Europe’s regulatory agency on Thursday said it would weigh COVID-19 vaccines for approval despite the efficacy potentially falling below a 50% threshold.
Novartis announced on Wednesday that the FDA granted Breakthrough Therapy designation to an experimental therapy that targets advanced castration-resistant prostate cancer.
Preliminary data behind German biopharmaceutical company CureVac's COVID-19 vaccine candidate revealed a disappointing 47% efficacy against COVID-19 disease of any severity, and failed to meet statistical success criteria in a late-stage trial, sending stocks tanking.
Australia has limited use of the AstraZeneca vaccine to those 60 and over, recommending that younger adults receive the Pfizer-BioNTech jab instead amid instances of rare, severe blood clots.
Indonesia’s president ordered authorities to speed up the country's vaccination campaign as the World Health Organization warned Thursday of the need to increase social restrictions in the country amid a fresh surge of coronavirus infections caused by worrisome variants.
As cases tumble and states reopen, the potential final stage in the U.S. campaign to vanquish COVID-19 is turning into a slog, with a worrisome variant gaining a bigger foothold and lotteries and other prizes failing to persuade some Americans to get vaccinated.
